Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endometrial Response in Women With Poorly Primed Endometrial Lining in Diagnosed Polyendocrine Metabolic Ovarian Syndrome (PMOS) Treated With Letrozole Alone or With Added Estradiol Valerate

NCT07379502 is registered in ClinicalTrials.gov with CMH Kharian Medical College as lead sponsor.

NCT NCT07379502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07379502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endometrial Response in Women With Poorly Primed Endometrial Lining in Diagnosed Polyendocrine Metabolic Ovarian Syndrome (PMOS) Treated With Letrozole Alone or With Added Estradiol Valerate
Lead sponsor
CMH Kharian Medical College
Phase
Not applicable
Overall status
Completed
Start date
March 5, 2026
Completion date
August 31, 2026
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polyendocrine metabolic ovarian syndrome (pmos)